Synthesized peptide derived from the C-terminal region of human ANKRD30A.
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:500-1:2000 IHC: 1:100-1:300 ELISA: 1:5000
General Notes
This product (Catalog No. DPABH-13279) is a rabbit-derived polyclonal antibody raised against human ANKRD30A. It has been affinity purified by Protein A. ANKRD30A (Ankyrin Repeat Domain 30A), also known as NY-BR-1, is a breast tissue-specific differentiation antigen and transcription factor, highly expressed in normal mammary gland and up to 80% of breast cancers. It functions as a potential tumor-associated antigen with autoimmunogenicity in breast cancer patients, with expression often found in both cytoplasm and nucleus. DPABH-13279 is suitable for use in Western blot (WB) (1:500–1:2,000), IHC (1:100–1:300), ELISA (1:5000) applications. DPABH-13279 is supplied as a liquid formulation in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
Target
Alternative Names
ANKRD30A; Ankyrin repeat domain-containing protein 30A; NY-BR-1
My Review for Rabbit Anti-Human ANKRD30A (C-terminal) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.